Obesity drug safety check: no cure, just compatibility
NCT ID NCT07269756
First seen Dec 08, 2025 · Last updated May 14, 2026 · Updated 17 times
Summary
This study looked at how an experimental drug for obesity (HRS-7535) interacts with four common medicines: acetaminophen (pain relief), digoxin (heart medication), rosuvastatin (cholesterol), and omeprazole (acid reflux). It involved 40 overweight or obese adults and measured drug levels in the blood. The goal was to gather safety information, not to treat obesity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Suzhou Municipal Hospital
Suzhou, Jiangsu, 215000, China
Conditions
Explore the condition pages connected to this study.